Publication | Closed Access

Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4

Molecular PharmacologyCardiac MuscleCardiomyopathyMolecular PhysiologyCardiovascular DiseaseCardiac HypertrophyMedicinePhysiologyCardiovascular PharmacologyP65-nfκb BindingPeroxisome Proliferator-activated Receptor-αCardiovascular FunctionMetabolic SignalingPharmacologyCardiologyCardiovascular Translational Research